Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
- PMID: 15051791
- DOI: 10.1200/JCO.2004.99.228
Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
Comment on
-
Quality trials and quality of life in non-small-cell lung cancer.J Clin Oncol. 2003 Aug 15;21(16):3007-8. doi: 10.1200/JCO.2003.05.079. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837809 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical